Instituto de Química Médica (IQM-CSIC), c/Juan de la Cierva 3, E-28006 Madrid, Spain.
KU Leuven - University of Leuven, Rega Institute for Medical Research, Minderboedersstraat 10 blok x - bus 1030, B-3000 Leuven, Belgium.
Eur J Med Chem. 2014 Nov 24;87:421-8. doi: 10.1016/j.ejmech.2014.09.093. Epub 2014 Sep 30.
A series of novel 6-phenylaminopurines have been efficiently synthesized in 3 steps exploring different groups at positions 2, 8 and 9 of the purine ring and at the exocyclic nitrogen atom at position 6. Among the newly described purines, five compounds showed antiproliferative activity with IC50 values below 10 μM, the tetrahydroquinoline derivative at position 6 of phenylaminopurine being the most active of the series in the six cell lines tested. Moreover, the compounds induced G2/M phase arrest in human cervical carcinoma HeLa cells as reported for tubulin depolymerizing agents.
已经通过 3 步反应,以高效的方式合成了一系列新型 6-芳基氨基嘌呤,该方法分别在嘌呤环的 2、8 和 9 位以及 6 位的环外氮原子上探索了不同的取代基。在所描述的新型嘌呤中,有 5 种化合物表现出抗增殖活性,IC50 值低于 10 μM,其中 6 位为四氢喹啉衍生物的苯基氨基嘌呤在测试的 6 种细胞系中活性最高。此外,正如报道的微管解聚剂一样,这些化合物可诱导人宫颈癌 HeLa 细胞发生 G2/M 期阻滞。